Skip to main content
. 2024 Nov 15;16(11):6699–6708. doi: 10.62347/KMLD8349

Table 1.

Comparison of baseline data between the two groups [n/(X̅±S)]

Group Control group (n=109) Study group (n=107) χ2/t P
Gender (Male/female) 63/46 60/47 0.065 0.798
Age (years) 56.85±5.63 57.12±5.41 0.359 0.720
Tumor site (colon/rectum) 60/49 61/46 0.085 0.771
Clinical stage (Stage II/III) 66/43 67/40 0.097 0.755
Pathologic classification (mucinous adenocarcinoma/tubular adenocarcinoma) 41/68 38/69 0.103 0.749